First Online: 20 July 2017
: S.K.K. has served as a consultant for Takeda, Amgen, AbbVie, Merck, Janssen and Skyline Dx. K.C.A. is a member of the advisory board for Millennium Pharmaceuticals, Bristol-Myers Squibb and Gilead Sciences, and is a Scientific Founder of OncoPep and C4 Therapeutics. R.A.K. serves on the disease monitoring committees for Celgene, Bristol-Myers Squibb, Onyx Pharmaceuticals (Amgen) and Pharmacyclics. P.S. is an adviser for Amgen, Bristol-Myers Squibb, Celgene, Janssen, Takeda and Skyline Dx, and has received research support from Amgen, Celgene, Janssen and Takeda. F.G. serves as an adviser for Celgene, Takeda, Roche, Seattle Genetics and Amgen, and has received honoraria from Celgene, Janssen, Amgen, Bristol-Myers Squib and Takeda. M.-V.M. is a consultant for Amgen, Celgene, Janssen and Takeda, and has received speaker's fees from Janssen, Celgene, Amgen and Takeda. V.R. and M.v.D. declare no competing interests.